Literature DB >> 26634613

The permeability characteristics and interaction of the main components from Zhizi Bopi decoction in the MDCK cell model.

Zhengyue Qian1, Cheng Huang1, Chenlin Shen1, Xiaoming Meng1, Zhaolin Chen1, Tingting Hu1, Yangyang Li1, Jun Li1.   

Abstract

1. Although emerging evidence indicates the therapeutic effects of Zhizi Bopi Decoction, the extent to which essential ingredients are absorbed and the possible synergistic actions are poorly understood. 2. In this study, MDCK cell model was used to determine the bi-directional permeability and interaction between the main components (geniposide, berberine and glycyrrhizic acid) of Zhizi Bopi Decoction. 3. The transport of the active ingredients was concentration-dependent in both directions. Moreover, the Papp (AP-BL) values of berberine and glycyrrhizic acid were significantly reduced when co-incubation with an ATP inhibitor. Additionally, uptake of berberine, glycyrrhizic acid were clearly inhibited by the inhibitors of P-glycoprotein and MRP2, indicating that P-gp and MRP2 may be involved in the transport of berberine and glycyrrhizic acid, respectively. However, it was found that geniposide may be purely passive diffusion. Furthermore, the combined incubation of geniposide with berberine and glycyrrhizic acid had a powerful sorbefacient effect than use of a single drug alone which may be regulated by tight junctions. 4. In summary, our study provides useful information for pharmacological applications of Zhizi Bopi Decoction and offers new insights into this ancient decoction for further researches, especially in drug synergism.

Entities:  

Keywords:  MDCK; MRP2; P-gp; Zhizi Bopi Decoction; tight junctions

Mesh:

Substances:

Year:  2015        PMID: 26634613     DOI: 10.3109/00498254.2015.1113575

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  2 in total

1.  Enhanced Anti-diabetic Effect of Berberine Combined With Timosaponin B2 in Goto-Kakizaki Rats, Associated With Increased Variety and Exposure of Effective Substances Through Intestinal Absorption.

Authors:  Xiaoting Tian; Fang Liu; Zhixiong Li; Yunfei Lin; Huan Liu; Pei Hu; Mingcang Chen; Zhaolin Sun; Zhou Xu; Yiting Zhang; Li Han; Yuanyuan Zhang; Guoyu Pan; Chenggang Huang
Journal:  Front Pharmacol       Date:  2019-01-24       Impact factor: 5.810

2.  Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters.

Authors:  Zipeng Gong; Qing Yang; Yajie Wang; Xiaogang Weng; Yujie Li; Yu Dong; Xiaoxin Zhu; Ying Chen
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.